Special Interest Group in Vaccines

Objectives

1. To foster development and adoption of methods to improve the accurate and efficient collection of vaccine exposure information (e.g., 2D barcodes, vaccine generic names, vaccine doses and dates of delivery) for each vaccinee.  Lot identifiers, in particular, would allow verification of the exact vaccine product (type and manufacturer) as well as linkage to details of vaccine antigens, preservatives, and excipients).
2. To foster development and sharing of new/existing methods for vaccine safety, effectiveness, usage, cost-benefit, risk-management/mitigation across the life cycle of vaccines from pre- to post-licensure, and from signal detection to hypothesis testing.
3. To provide a forum for interaction with regulatory authorities and public health agencies to raise awareness and stimulate incorporation of vaccine specific and relevant aspects into regulations and regulatory templates.
4. To assist low and middle-income countries with development of their data collection and technical expertise in vaccine pharmacoepidemiology.

Mission

The SIG strives to achieve these goals by offering a platform for interested ISPE members to plan educational activities for the ICPE pre-conference courses together with the education committee, shared national and international projects and grant proposals, and joined presentation in form of workshops, symposia or poster walks at annual ICPE meetings. Whenever possible, the VAX SIG will seek to maximize synergy with existing vaccine institutions and stakeholders.

Committee Leaders

Workgroup Leaders

Members

Dates of Meetings

Occurs the first Wednesday of every month at 9:00 am EST (UTC/GMT -5 hours). Interested persons should email James Stark: James.Stark@pfizer.com

Meeting Minutes

2018

Content